Press release
Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) Long Term should contact the Shareholders Foundation in connection with Investigation of potential Wrongdoing
An investigation on behalf of current long term investors in BioAge Labs, Inc. (NASDAQ: BIOA) shares.
Investors who are current long term investors in BioAge Labs, Inc. (NASDAQ: BIOA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: BIOA stocks follows a lawsuit filed against BioAge Labs, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: BIOA stocks, concerns whether certain BioAge Labs, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to the complaint the plaintiff alleges on behalf of purchasers of BioAge Labs, Inc. (NASDAQ: BIOA) common shares pursuant and/or traceable to BioAge's registration statement for the initial public offering held on or about September 26, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the December 6, 2024 announcement by BIoAge Labs, Inc came as a surprise because, at the time of its IPO less than three months earlier, BioAge highlighted azelaprag's potential in patients undergoing obesity therapy with incretin drugs, and that investors who purchased BioAge Labs, Inc. (NASDAQ: BIOA) common shares pursuant and/or traceable to BioAge's registration statement for the initial public offering held on or about September 26, 2024 bought BioAge stock based on false and/or materially misleading information concerning its STRIDES Phase 2 clinical trial and that these investors sustained damages as a result thereof.
Those who purchased shares of BioAge Labs, Inc. (NASDAQ: BIOA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) Long Term should contact the Shareholders Foundation in connection with Investigation of potential Wrongdoing here
News-ID: 3986914 • Views: …
More Releases from Shareholders Foundation, Inc.
Investigation announced for Long-Term Investors in shares of Fly-E Group, Inc. ( …
An investigation was announced for investors in shares of Fly-E Group, Inc. (NASDAQ: FLYE) concerning potential breaches of fiduciary duties by certain directors and officers of Fly-E Group, Inc.
Investors who are current long term investors in Fly-E Group, Inc. (NASDAQ: FLYE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Lawsuit filed for Investors who lost money with shares of agilon health, inc. (N …
An investor, who purchased shares of agilon health, inc. (NYSE: AGL), filed a lawsuit over alleged violations of Federal Securities Laws by agilon health, inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of agilon health, inc. (NYSE: AGL) have certain options and for certain investors are short and strict deadlines running. Deadline: March 2, 2026. NYSE: AGL investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Long-Term Investors in shares of Semler Scientific, …
An investigation was announced for current long-term investors in shares of Semler Scientific, Inc. (NASDAQ: SMLR) concerning potential breaches of fiduciary duties by certain directors and officers of Semler Scientific, Inc.
Investors who are current long term investors in Semler Scientific, Inc. (NASDAQ: SMLR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors in shares of Klarna Group plc (NYSE: KLAR) over alle …
An investor, who purchased shares of Klarna Group plc (NYSE: KLAR), filed a lawsuit in the U.S. k over alleged violations of Federal Securities Laws by Klarna Group plc in connection with certain allegedly false and misleading statements made issued in connection with Klarna's September 10, 2025 initial public offering (the "IPO").
Investors who purchased a significant amount of shares of Klarna Group plc (NYSE: KLAR) have certain options and for…
More Releases for BioAge
AI for Predictive Drug Response Modeling Market Is Going to Boom | Major Giants …
HTF MI just released the Global AI for Predictive Drug Response Modeling Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in AI for Predictive…
BioAge Labs, Inc. (NASDAQ: BIOA) Investor Notice: Deadline in Lawsuit on March 1 …
A deadline is coming up on March 10, 2025 in the lawsuit filed for certain investors of BioAge Labs, Inc. (NASDAQ: BIOA) over alleged securities laws violations by BioAge Labs, Inc.
Investors who purchased shares of BioAge Labs, Inc. (NASDAQ: BIOA) have certain options and there are strict and short deadlines running. Deadline: March 10, 2025. NASDAQ: BIOA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Lawsuit filed for Investors who lost money with shares of BioAge Labs, Inc. (NAS …
An investor, who purchased shares of BioAge Labs, Inc. (NASDAQ: BIOA), filed a lawsuit over alleged violations of Federal Securities Laws by BioAge Labs, Inc. in connection with certain allegedly false and misleading statements made in connection BioAge Labs, Inc's initial public offering held on or about September 26, 2024.
Investors who purchased shares of BioAge Labs, Inc. (NASDAQ: BIOA) have certain options and for certain investors are short and…
AI for Drug Discovery Market: Intense Competition but High Growth & Extreme Valu …
Advance Market Analytics published a new research publication on "AI for Drug Discovery Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI for Drug Discovery market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive…
AI for Drug Discovery – Market Boosting the Growth Worldwide: Atomwise, BIOAGE …
Latest Study on Industrial Growth of Worldwide AI for Drug Discovery Market 2021-2027. A detailed study accumulated to offer Latest insights about acute features of the Worldwide AI for Drug Discovery market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
AI for Drug Discovery Market Size, Strategy, Business Outlook to 2027 - Atomwise …
Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency,…
